Harvard Bioscience, Inc. (HBIO)

NASDAQ: HBIO · Real-Time Price · USD

5.34

+0.07 (1.33%)

At close: Mar 23, 2026, 4:00 PM EDT

5.34

0.00 (0.00%)

After-hours: Mar 23, 2026, 4:10 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medical Products	86.55M	94.14M	112.25M	113.34M	118.90M
Medical Products Growth	-8.06%	-16.14%	-0.96%	-4.68%	16.46%
Total	86.55M	94.14M	112.25M	113.34M	118.90M
Total Growth	-8.06%	-16.14%	-0.96%	-4.68%	16.46%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	38.97M	41.74M	48.21M	49.91M	49.83M
United States Growth	-6.64%	-13.42%	-3.42%	0.16%	18.49%
Americas - Other	3.23M	3.60M	3.52M	-	-
Americas - Other Growth	-10.26%	2.25%	-	-	-
Europe, Middle East and Africa	26.71M	28.41M	33.28M	-	-
Europe, Middle East and Africa Growth	-5.97%	-14.64%	-	-	-
China	10.97M	13.30M	18.49M	16.39M	13.50M
China Growth	-17.51%	-28.08%	12.78%	21.47%	-
Asia - Other	6.68M	7.10M	8.77M	-	-
Asia - Other Growth	-5.93%	-19.01%	-	-	-
Rest of the World	-	-	-	16.34M	19.81M
Rest of the World Growth	-	-	-	-17.50%	218.28%
Europe	-	-	-	30.69M	35.77M
Europe Growth	-	-	-	-14.20%	19.47%
Total	86.55M	94.14M	112.25M	113.34M	118.90M
Total Growth	-8.06%	-16.14%	-0.96%	-4.68%	16.46%

Source: S&P Global Market Intelligence.